获礼来收购预期升温 Abivax(ABVX.US)开盘大涨逼近历史新高

Core Viewpoint - Abivax S.A. experienced a nearly 15% increase in stock price, approaching its historical high, following reports of Eli Lilly's interest in acquiring the biotechnology company [1] Group 1: Company Developments - Eli Lilly has initiated preliminary discussions with French authorities to explore a potential acquisition of Abivax [1] - The discussions included meetings with the French Ministry of Finance in early December to assess any foreign investment review regulations that may impact the acquisition [1] - Eli Lilly also considered the involvement of state investor Bpifrance as a minority shareholder in the potential acquisition [1]